Evolution of Biogen Idec's Pipeline

For the first 20 years after its formation in 1978, Biogen Inc., now called Biogen Idec Inc. (NASDAQ:BIIB), followed an opportunistic R&D strategy, with a focus on immunology. In 1999, the company emb...